"Holy Family Hospital is a 385-bed full-service, acute care hospital with two campuses located in Methuen and Haverhill, Massachusetts. Both locations, Holy Family Hospital-Methuen, and Holy Family Hospital-Haverhill, provide comprehensive inpatient, outpatient and 24/7 emergency services, including eICUs. With first class specialists, innovative treatment options and state-of-the-art technology, both of our hospital campuses provide exceptional care throughout the greater Merrimack Valley and southern New Hampshire."

During the past decade, Holy Family Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 23 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holy Family Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "SWOG Cancer Research Network" with 9 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored, "Baim Institute for Clinical Research" with 2 trials sponsored and "Novartis Pharmaceuticals" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holy Family Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "NRG Oncology" with 3 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Holy Family Hospital" are "Breast Cancer" (7 trials), "Recurrent Breast Carcinoma" (3 trials), "Breast Adenocarcinoma" (2 trials), "Breast Ductal Carcinoma In Situ" (2 trials) and "HER2/Neu Positive" (2 trials). Many other conditions were trialed in "Holy Family Hospital" in a lesser frequency.

Most popular intervention types in "Holy Family Hospital" are "Drug" (27 trials), "Other" (16 trials), "Biological" (14 trials), "Procedure" (6 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (13 trials), "Bevacizumab" (8 trials), "Paclitaxel" (5 trials), "Docetaxel" (4 trials) and "Letrozole" (4 trials). Other intervention names were less common.

The vast majority of trials in "Holy Family Hospital" are 18 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Holy Family Hospital". undefined are not yet recruiting, undefined are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Holy Family Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Holy Family Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Holy Family Hospital has several departments that took part in Clinical trials: "Dana Farber Community Cancer Care-Haverhill" - 4 trials